Track the 우정바이오 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 우정바이오 has recorded 4 public disclosures. Market capitalisation: €37.9bn. The latest transaction was reported on 23 June 2026 (Other). Among the most active insiders: 우정바이오. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
우정바이오 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于生物制药产品的开发。